Detalhe da pesquisa
1.
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
Clin Infect Dis
; 75(4): 682-689, 2022 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34849645
2.
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(9): e0040822, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35916515
3.
Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
J Antimicrob Chemother
; 76(4): 1019-1024, 2021 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33378452
4.
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32778547
5.
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30858211
6.
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31061152
7.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet
; 392(10150): 821-834, 2018 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30215381
8.
Reply to Upton et al.
Clin Infect Dis
; 77(1): 158-159, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36978221
9.
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 21(6): 992-1001, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25993036
10.
Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.
Clin Infect Dis
; 59(11): 1559-66, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25091301
11.
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks.
Tuberculosis (Edinb)
; 144: 102462, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38070353
12.
HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis.
medRxiv
; 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37293036
13.
The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation.
Int J Antimicrob Agents
; 62(4): 106939, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37517627
14.
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks.
medRxiv
; 2023 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37425849
15.
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.
medRxiv
; 2023 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38168338
16.
Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis.
Front Pharmacol
; 13: 1048653, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36578553
17.
Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance.
PLoS One
; 17(6): e0270201, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35749509
18.
Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.
Open Forum Infect Dis
; 8(12): ofab551, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34877367
19.
Does optimized adherence support improve treatment outcomes in RR / MDR-TB patients on 18-20 months regimen in Tbilisi, Georgia?
J Infect Dev Ctries
; 15(9.1): 34S-42S, 2021 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34609958
20.
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet Respir Med
; 8(4): 383-394, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32192585